Bar Leone Crowned The World’s Best Bar 2025 in Its Hometown of Hong Kong 8-10-2025, 23:23

Education Ecosystem Set to Launch New Web App 18-02-2023, 02:06

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26